Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Carl Zeiss Meditec AG (AFXd)

BATS Europe
Currency in EUR
58.60
0.00(0.00%)
Delayed Data

AFXd Income Statement

Advanced Income Statement
Period Ending:
2014
30/09
2015
30/09
2016
30/09
2017
30/09
2018
30/09
2019
30/09
2020
30/09
2021
30/09
2022
30/09
2023
30/09
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa1,459.321,335.451,646.791,902.842,089.3
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+13.93%-8.49%+23.31%+15.55%+9.8%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa627.44589.94679.57775.24883.54
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa831.88745.52967.211,127.61,205.77
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+17.1%-10.38%+29.74%+16.58%+6.93%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa57%55.83%58.73%59.26%57.71%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa567.78568.59596.83729.92852.1
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+10.49%+0.14%+4.97%+22.3%+16.74%
aa.aaaa.aaaa.aaaa.aaaa.aa173.31218.8232.07291.37349.28
aa.aaaa.aaaa.aaaa.aaaa.aa394.47349.78364.77438.55502.82
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa264.1176.93370.38397.68353.67
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+34.38%-33.01%+109.34%+7.37%-11.07%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa18.1%13.25%22.49%20.9%16.93%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-5.85-25.81-7.024.1512.86
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-444.19%-341.18%+72.82%+159.16%+209.83%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-7.65-27.27-8.58-9.1-15.25
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa1.81.461.5613.2528.11
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-28.394.47-25.02-50.7935.46
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa229.86155.59338.35351.04401.98
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa--2.45--
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-23.13-1.8452.4510.88
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa229.86178.72339.05403.49412.56
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+28.28%-22.25%+89.71%+19.01%+2.25%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa15.75%13.38%20.59%21.2%19.75%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa69.2855.3101.53107.58120.56
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa160.58123.42237.52295.91292.01
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-0.82-1.04-1.24-2-1.61
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa159.76122.39236.28293.91290.4
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+26.33%-23.39%+93.06%+24.39%-1.2%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa10.95%9.16%14.35%15.45%13.9%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa159.76122.39236.28293.91290.4
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa1.791.372.643.293.25
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+26.33%-23.39%+93.06%+24.39%-1.2%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa1.791.372.643.293.25
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+26.33%-23.39%+93.06%+24.39%-1.2%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa89.4489.4489.4489.4489.44
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa89.4489.4489.4489.4489.44
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa0.650.50.91.11.1
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+18.18%-23.08%+80%+22.22%0%
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa284.04200.04388.94418.29375.31
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+30.51%-29.57%+94.43%+7.55%-10.27%
EBITDA Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa